| Particulars (Rupees in Crores.) | Sept-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sept-2024 |
|---|---|---|---|---|---|
Gross Sales | 423.99 | 441.42 | 401.7 | 390.81 | 368.65 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 423.99 | 441.42 | 401.7 | 390.81 | 368.65 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.15 | 3.87 | 1.66 | 5.84 | 4.51 |
Total Income | 426.14 | 445.29 | 403.36 | 396.65 | 373.16 |
Total Expenditure | 370.01 | 390.48 | 355.8 | 356.62 | 333.87 |
PBIDT | 56.13 | 54.81 | 47.56 | 40.03 | 39.29 |
Interest | 13.51 | 14.16 | 15.13 | 14.95 | 14.29 |
PBDT | 42.62 | 40.65 | 32.43 | 25.08 | 25 |
Depreciation | 15.46 | 15.13 | 16.12 | 16.98 | 17.1 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 7.24 | 13.63 | 12.93 | 8.83 | 7.97 |
Deferred Tax | 0.32 | -5.68 | -7 | -7.21 | -6.41 |
Reported Profit After Tax | 19.6 | 17.57 | 10.38 | 6.48 | 6.34 |
Minority Interest After NP | 4.86 | 3.26 | 1.06 | 3.04 | 3.73 |
Net Profit after Minority Interest | 14.74 | 14.31 | 9.32 | 3.44 | 2.61 |
Extra-ordinary Items | -1.23 | -0.58 | -0.07 | 0.03 | 0.04 |
Adjusted Profit After Extra-ordinary item | 15.97 | 14.89 | 9.39 | 3.41 | 2.57 |
EPS (Unit Curr.) | 0.59 | 0.57 | 0.37 | 0.14 | 0.11 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 50.33 | 50.07 | 50.06 | 50.06 | 49.92 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 13.23 | 12.41 | 11.83 | 10.24 | 10.65 |
PBDTM(%) | 10.05 | 9.2 | 8.07 | 6.41 | 6.78 |
PATM(%) | 4.62 | 3.98 | 2.58 | 1.65 | 1.71 |
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.